BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3265498)

  • 21. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40.
    Crawford DH; Catovsky D
    Immunology; 1993 Sep; 80(1):40-4. PubMed ID: 7503945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
    Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
    Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
    Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].
    Rupniewska ZM; Wach M; Kowal M; Roliński J; Antosz H
    Acta Haematol Pol; 1992; 23(1):21-7. PubMed ID: 1615748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
    Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
    Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunosuppressor activity of B-cells in patients with chronic lymphocytic leukemia. Their possible role in the pathogenesis of the disease].
    Chernykh ER; Tikhonova MA; Ostanin AA; Shevela EIa; Blazhievich IA; Shubinskiĭ GZ
    Vestn Akad Med Nauk SSSR; 1991; (12):39-43. PubMed ID: 1801472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors.
    Chiotoglou I; Smilevska T; Samara M; Likousi S; Belessi C; Athanasiadou I; Stavroyianni N; Samara S; Laoutaris N; Vamvakopoulos N; Anagnostopoulos A; Fassas A; Stamatopoulos K; Kollia P
    Blood Cells Mol Dis; 2008; 41(2):203-9. PubMed ID: 18621559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
    Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
    Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
    Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
    Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
    Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
    J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.
    Scielzo C; Ghia P; Conti A; Bachi A; Guida G; Geuna M; Alessio M; Caligaris-Cappio F
    J Clin Invest; 2005 Jun; 115(6):1644-50. PubMed ID: 15931393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes.
    Porakishvili N; Kulikova N; Jewell AP; Youinou PY; Yong K; Nathwani A; Heelan B; Duke V; Hamblin TJ; Wallace P; Ely P; Clark EA; Lydyard PM
    Br J Haematol; 2005 Nov; 131(3):313-9. PubMed ID: 16225650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
    al-Katib A; Mohammad RM; Dan M; Hussein ME; Akhtar A; Pettit GR; Sensenbrenner LL
    Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
    Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
    Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Functional properties of B-lymphocytes of patients with a B-cell variant of chronic lymphocytic leukemia and chronic glomerulonephritis].
    Ostanin AA; Chernykh ER; Shubinskiĭ GZ; Nekipelova VI; Tov NL; Lozovoĭ VP
    Vestn Akad Med Nauk SSSR; 1991; (12):19-23. PubMed ID: 1801468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment and characterization of a malignant lymphoid cell line from a chronic lymphocytic leukemia patient.
    Gazitt Y; He YJ; Chang L; Gangavalli A; Hubbard WJ; Oldham RK
    Mol Biother; 1989; 1(6):328-33. PubMed ID: 2610952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunoregulating effect of prostaglandins on the course of chronic lympholeukemia].
    Shalaev VA; Makeev OG; Krylova IV; Isakov SV
    Ter Arkh; 1989; 61(7):26-9. PubMed ID: 2588138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic lymphocytic leukemia. II. Differentiation of various forms of chronic lymphocytic leukemia by cytological and immunological indicators].
    Popova L; Apostolov P; Vlaĭkova S; Stamenova L
    Vutr Boles; 1988; 27(3):76-80. PubMed ID: 3264645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute monocytic leukemia with B cell markers expression following B chronic lymphocytic leukemia.
    Lavabre-Bertrand T; Donadio D; Breton A; Taib J; Charlier D; Assens C; Poncelet P; Murgue B; Vendrell JP; Emberger JM
    Nouv Rev Fr Hematol (1978); 1989; 31(5):345-8. PubMed ID: 2587203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease.
    Tötterman TH; Carlsson M; Simonsson B; Bengtsson M; Nilsson K
    Blood; 1989 Aug; 74(2):786-92. PubMed ID: 2787679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.